MedTrace Logo

Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate

NCT01913392 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2019-12-02

No results posted yet for this study

Summary

A prospective clinical trial will study the effects of laparoscopic sleeve gastrectomy in the potential renal transplant candidate who is denied acceptance due mainly to the morbid obesity.

Conditions

  • Obesity, Morbid
  • Transplant; Failure, Kidney

Interventions

PROCEDURE

laparoscopic sleeve gastrectomy

Sponsors & Collaborators

  • Canadian surgical research fund

    collaborator UNKNOWN

  • Astellas Pharma Canada, Inc.

    collaborator INDUSTRY

  • Maisonneuve-Rosemont Hospital

    lead OTHER

Principal Investigators

  • Gabriel Chan, MD · Maisonneuve-Rosemont Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-18
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01913392 on ClinicalTrials.gov